| Dr Daniel Raymond Albrecht, MD | |
|
1200 Ne 48th Ave Ste 1100, Hillsboro, OR 97124-5062 | |
| (503) 844-8310 | |
| (503) 844-8316 |
| Full Name | Dr Daniel Raymond Albrecht |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 18 Years |
| Location | 1200 Ne 48th Ave Ste 1100, Hillsboro, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720206261 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD155693 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tuality Community Hospital | Hillsboro, OR | Hospital |
| Ohsu Hospital And Clinics | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tuality Medical Group Llc | 7416173414 | 245 |
News Archive
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
Gilead Sciences, Inc. today announced that aztreonam for inhalation solution, an investigational product for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF), is scheduled to be reviewed by the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) on December 10, 2009.
DSM, a global leader in biomedical materials sciences, and AxioMed Spine Corporation, an innovator in the field of spinal implant devices, today announced that they have revised and extended an existing licensing and supply agreement. DSM will supply its proprietary CarboSil®Thermoplastic Silicone-Polycarbonate-urethane material for use in AxioMed's Freedom® Lumbar and Freedom® Cervical Discs.
A new strategy may help halt the progression of kidney disease in patients with diabetes.
› Verified 9 days ago
| Entity Name | Tuality Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275591984 PECOS PAC ID: 3678486107 Enrollment ID: O20040130000359 |
News Archive
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
Gilead Sciences, Inc. today announced that aztreonam for inhalation solution, an investigational product for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF), is scheduled to be reviewed by the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) on December 10, 2009.
DSM, a global leader in biomedical materials sciences, and AxioMed Spine Corporation, an innovator in the field of spinal implant devices, today announced that they have revised and extended an existing licensing and supply agreement. DSM will supply its proprietary CarboSil®Thermoplastic Silicone-Polycarbonate-urethane material for use in AxioMed's Freedom® Lumbar and Freedom® Cervical Discs.
A new strategy may help halt the progression of kidney disease in patients with diabetes.
› Verified 9 days ago
| Entity Name | Tuality Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
Gilead Sciences, Inc. today announced that aztreonam for inhalation solution, an investigational product for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF), is scheduled to be reviewed by the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) on December 10, 2009.
DSM, a global leader in biomedical materials sciences, and AxioMed Spine Corporation, an innovator in the field of spinal implant devices, today announced that they have revised and extended an existing licensing and supply agreement. DSM will supply its proprietary CarboSil®Thermoplastic Silicone-Polycarbonate-urethane material for use in AxioMed's Freedom® Lumbar and Freedom® Cervical Discs.
A new strategy may help halt the progression of kidney disease in patients with diabetes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Raymond Albrecht, MD 1200 Ne 48th Ave Ste 1100, Hillsboro, OR 97124-5062 Ph: (503) 844-8310 | Dr Daniel Raymond Albrecht, MD 1200 Ne 48th Ave Ste 1100, Hillsboro, OR 97124-5062 Ph: (503) 844-8310 |
News Archive
Celtic Pharmaceutical Holdings L.P. today announced that the U.S. Patent Office has issued U.S. patent 7,816,323, for novel methods to treat breast and colon cancers using a combination therapy of Xerecept with Avastin.
Gilead Sciences, Inc. today announced that aztreonam for inhalation solution, an investigational product for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF), is scheduled to be reviewed by the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) on December 10, 2009.
DSM, a global leader in biomedical materials sciences, and AxioMed Spine Corporation, an innovator in the field of spinal implant devices, today announced that they have revised and extended an existing licensing and supply agreement. DSM will supply its proprietary CarboSil®Thermoplastic Silicone-Polycarbonate-urethane material for use in AxioMed's Freedom® Lumbar and Freedom® Cervical Discs.
A new strategy may help halt the progression of kidney disease in patients with diabetes.
› Verified 9 days ago
Jennifer Lee Johnson, MPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 335 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-640-6064 Fax: 503-693-2330 | |
Anuja Sharadchandra Chitale, PHYSICAL THERAPIST Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 5262 Ne Brookwood Pkwy, Hillsboro, OR 97124 Phone: 503-395-3000 | |
Nicole C Gregoire-smith, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2500 Nw 229th Ave Ste 200, Hillsboro, OR 97124 Phone: 503-395-3000 Fax: 503-336-0464 | |
Isaac Cowart, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2500 Nw 229th Ave Bldg E, Suite 200, Hillsboro, OR 97124 Phone: 503-395-3000 Fax: 503-336-0464 |